MA S2520 | 2023-2024 | 193rd General Court
Note: Replaces legislation S2499
Status
Spectrum: Slight Partisan Bill (Democrat 28-9-3-1)
Status: Engrossed on November 15 2023 - 50% progression
Action: 2023-11-20 - Read; and referred to the committee on House Ways and Means
Pending: House Ways and Means Committee
Text: Latest bill text (Introduced) [PDF]
Status: Engrossed on November 15 2023 - 50% progression
Action: 2023-11-20 - Read; and referred to the committee on House Ways and Means
Pending: House Ways and Means Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Relative to pharmaceutical access, costs and transparency
Title
Relative to pharmaceutical access, costs and transparency
Sponsors
Roll Calls
2023-11-15 - Senate - Senate Engrossed Roll Call #99 (Y: 39 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-11-20 | House | Read; and referred to the committee on House Ways and Means |
| 2023-11-15 | Senate | Passed to be engrossed -see Roll Call #99 (Yeas 39 to Nays 0) |
| 2023-11-15 | Senate | New draft of S2499 |
| 2023-11-15 | Senate | Reported from the committee on Senate Bills in the Third Reading |
Same As/Similar To
S2499 (Replaces) 2023-11-15 - Bills in the Third Reading report, substituting a new draft S2520, accepted
S2492 (Similar To) 2023-11-15 - Read second
S749 (Similar To) 2023-10-30 - Accompanied a new draft, see S2492
S2492 (Similar To) 2023-11-15 - Read second
S749 (Similar To) 2023-10-30 - Accompanied a new draft, see S2492
Massachusetts State Sources
| Type | Source |
|---|---|
| Summary | https://malegislature.gov/Bills/193/S2520 |
| Text | https://malegislature.gov/Bills/193/S2520.pdf |
| Roll Call | https://malegislature.gov/RollCall/193/SenateRollCall99.pdf |
